Results 41 to 50 of about 161 (131)

Clinical and Immunological Responses to Dermatophagoides farinae Allergen Immunotherapy in Dogs With Atopic Dermatitis

open access: yesVeterinary Dermatology, Volume 37, Issue 6, Page 924-932, December 2026.
Background: Atopic dermatitis (AD) in dogs is a prevalent allergic disorder associated with environmental allergens, including the house dust mite Dermatophagoides farinae (Df). Hypothesis/Objectives: To describe clinical and immunological changes over time in dogs with canine (c)AD sensitised to Df undergoing Df allergen‐specific immunotherapy (ASIT ...
Jakaphan Wannawong   +8 more
wiley   +1 more source

A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast (Malassezia pachydermatis) Otitis Externa in Dogs

open access: yesVeterinary Dermatology, Volume 37, Issue 6, Page 1020-1028, December 2026.
Background: Otitis externa (OE) with Malassezia pachydermatis overgrowth with limited bacterial involvement is common in dogs. Treatment with products containing antibiotics is unnecessary and not consistent with judicious use of antimicrobials.
Zorica Zivkovic Baks   +4 more
wiley   +1 more source

Nemolizumab for Pruritus Control in Cutaneous T‐Cell Lymphoma: A Case Series

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela   +2 more
wiley   +1 more source

Treatment of Canine Atopic Dermatitis: Updated Guidelines From the International Committee on Allergic Diseases of Animals (ICADA)

open access: yesVeterinary Dermatology, Volume 37, Issue 6, Page 963-989, December 2026.
ABSTRACT Background Canine atopic dermatitis (cAD) is a genetically, aetiologically, immunologically and clinically complex disease requiring both individualised immediate and long‐term management. Objectives These updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA) aim to substantially revise previous ...
Ralf S. Mueller   +4 more
wiley   +1 more source

S1PR3 mediates itch and pain via distinct TRP channel-dependent pathways

open access: yes, 2017
Sphingosine 1-phosphate (S1P) is a bioactive signaling lipid associated with a variety of chronic pain and itch disorders. S1P signaling has been linked to cutaneous pain, but its role in itch has not yet been studied. Here we find that S1P triggers itch
Rachel B. Brem   +3 more
core   +1 more source

Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects

open access: yesInternational Journal of Nanomedicine, 2019
Yixuan Wang, Sisi Cao, Kaiyue Yu, Fengdie Yang, Xiuming Yu, Yuanhao Zhai, Chuanbin Wu, Yuehong XuDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People’s Republic of ChinaBackground: Topical
Wang Y   +7 more
doaj  

Proactive Treatment of Canine Allergic Otitis Externa With Hydrocortisone Aceponate: A Retrospective Observational Study

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
In 71 dogs with allergic otitis externa receiving proactive hydrocortisone aceponate maintenance therapy after clinical and cytological remission, 70.4% had no relapse and 87.3% had no relapse or only one relapse during a fixed 12‐month observation period.
Elisa Maina   +4 more
wiley   +1 more source

Meta‐Analysis: The Placebo Response in Modern Treatments for Cholestatic Pruritus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 10, Page 1348-1361, November 2026.
Placebo arms show substantial improvement in cholestatic pruritus, with up to 30% response rate. Estimates differed across outcome instruments, highlighting the importance of endpoint selection and realistic placebo assumptions in future trial design.
Igor Boechat Silveira   +8 more
wiley   +1 more source

Pruritus Is Frequent and Persistent and Impacts Quality of Life Among Patients With Primary Sclerosing Cholangitis

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1288-1297, November 2026.
Among 200 patients with primary sclerosing cholangitis, 38% reported moderate to severe pruritus in the past 6 months. During 6 months of follow up, pruritus severity fluctuated significantly. Pruritus severity was linked to worse colitis activity and lower quality of life.
Richard Dean   +16 more
wiley   +1 more source

TOPICAL THERAPY IN PEDIATRIC DERMATOLOGY [PDF]

open access: yes, 2004
RESUMO Todos sabemos que as crianças não são meramente pequenos adultos. Em comparação com aqueles, estas apresentam uma relação superfície cutânea/ peso corporal aumentada que contribui, por um lado, para aumentar a susceptibilidade à irritação ...
Horta, M., Rocha, N., Selores, M.
core  

Home - About - Disclaimer - Privacy